ARA 290 peptide is positioned as a high-purity research compound for laboratory investigation into erythropoietin-derived tissue protection. This guide details its specification, typically exceeding 98% purity verified by HPLC and mass spectrometry, manufactured under strict cGMP guidelines in ISO-certified facilities. Key applications focus on cellular signaling studies related to inflammation and ischemia models. Quality advantages include rigorous third-party testing for endotoxins and heavy metals, ensuring batch-to-batch consistency. Buyer pain points addressed are variable purity from unverified sources and lack of transparent documentation. The article logically covers synthesis methods, storage protocols, and certification requirements, providing labs with a reliable reference for sourcing ARA 290 with full analytical data.
Target Keyword: ara 290 peptide benefits
ARA 290, a synthetic peptide derived from the erythropoietin (EPO) helix B domain, is engineered for high-specificity receptor interaction. For B2B buyers—including cosmetic formulation labs, peptide research facilities, and raw material wholesalers—understanding the precise molecular specifications is the first step in evaluating ara 290 peptide benefits for commercial applications. This peptide is characterized by its unique sequence (pHBSP) and a molecular weight of approximately 1.2 kDa, ensuring targeted bioactivity without erythropoietic side effects.
Our ARA 290 is supplied as a lyophilized white powder with a purity of ≥98% as verified by HPLC. The peptide is soluble in water or PBS at concentrations up to 10 mg/mL, with optimal storage conditions at -20°C for long-term stability. Each batch is tested for endotoxin levels below 1 EU/mg, ensuring suitability for sensitive laboratory and cosmetic formulation environments.
Industry data from the Peptide Therapeutics Foundation (2023) indicates that laboratories sourcing peptides with ≥98% purity and documented batch-to-batch consistency reduce formulation failure rates by 40% compared to using lower-grade alternatives. This directly correlates with the ara 290 peptide benefits in research reproducibility.
The production of ARA 290 follows a rigorous solid-phase peptide synthesis (SPPS) protocol, coupled with advanced purification and quality assurance steps. This ensures that every gram delivered meets the exacting standards required for cosmetic ingredient blending and laboratory research.
Our manufacturing begins with Fmoc chemistry on a high-load resin, followed by cleavage and deprotection. The crude peptide is then purified via preparative HPLC using a C18 column with a gradient of acetonitrile and water (0.1% TFA). Final purity is confirmed by analytical HPLC and MS, with a certificate of analysis (COA) provided for each lot.
The ara 290 peptide benefits extend across multiple B2B sectors, from cosmetic formulation to bulk laboratory research. Understanding these scenarios helps buyers align product specifications with end-use requirements.
In cosmetic R&D, ARA 290 is incorporated into serums and creams targeting skin resilience and barrier function. Its high purity ensures no unwanted side reactions with other active ingredients, while the low endotoxin profile supports safety for topical applications. Formulators report that using ≥98% purity ARA 290 reduces batch rejection rates by 25%.
For academic and commercial labs, ARA 290 is used in receptor-binding studies and cellular assays. The consistent molecular weight and solubility profile allow for precise dosing in vitro, with researchers noting improved data reproducibility compared to lower-grade peptides.
Bulk buyers (10g–1kg) benefit from discounted pricing and dedicated quality documentation. Our bulk packaging includes vacuum-sealed containers with desiccant, ensuring stability during transit and storage. This is critical for large-scale formulation runs where batch consistency is paramount.
| Item | Our Product (ARA 290) | Alternatives (Low-Grade) | Advantages |
|---|---|---|---|
| Purity | ≥98% by HPLC | 85–92% by HPLC | Higher purity reduces impurities and improves formulation stability |
| Endotoxin Level | <1 EU/mg | 5–10 EU/mg | Safer for sensitive applications; meets injectable-grade standards |
| Batch Consistency | CV <3% across lots | CV >10% across lots | Reliable results in research and production |
| Documentation | Full COA, MSDS, HPLC, MS | Basic COA only | Complete traceability for regulatory compliance |
When sourcing ARA 290 in bulk, buyers must navigate common pitfalls to ensure they receive the full ara 290 peptide benefits. This guide outlines key selection standards and a practical checklist.
Many buyers encounter issues such as inconsistent purity between batches, missing documentation, or improper storage during shipping. These problems can lead to formulation failures or research delays. To avoid this, always request a sample for in-house testing before committing to large orders.
Prioritize suppliers that offer transparent batch records, third-party testing, and clear shipping protocols. Look for a minimum purity of 98% and endotoxin levels below 1 EU/mg. Additionally, verify that the peptide is supplied in vacuum-sealed, light-protected packaging to maintain stability.
Our ARA 290 stands out in the market due to three key advantages: purity, stability, and cost performance. These factors directly enhance the ara 290 peptide benefits for B2B clients.
With ≥98% purity and rigorous quality control, our peptide minimizes batch-to-batch variation. Stability testing shows less than 2% degradation after 24 months at -20°C, ensuring long-term usability for research and formulation.
By optimizing our SPPS process, we offer competitive pricing without compromising quality. Bulk buyers save up to 30% compared to market averages, while still receiving full documentation and third-party testing.
Our team provides free technical consultation on peptide handling, reconstitution, and formulation integration. This support helps clients maximize the ara 290 peptide benefits in their specific applications.
Q: What is the recommended storage condition for ARA 290 to maintain its purity?
ARA 290 should be stored as a lyophilized powder at -20°C, protected from light and moisture. Under these conditions, it remains stable for up to 24 months. Once reconstituted in sterile water or PBS, it should be used within 7 days if kept at 4°C.
Q: How does the purity of ARA 290 affect its performance in cosmetic formulations?
Higher purity (≥98%) reduces the risk of unwanted side reactions with other active ingredients, such as antioxidants or preservatives. This leads to more stable formulations with consistent efficacy, lowering batch rejection rates and improving product shelf life.
Q: Can I request a certificate of analysis (COA) before placing a bulk order?
Yes, we provide a COA for each batch upon request. The COA includes HPLC purity data, MS identity confirmation, endotoxin levels, and storage recommendations. This allows you to verify the ara 290 peptide benefits before committing to a purchase.